Drug Profile
R 103
Alternative Names: ABS 103R; R ABS 103Latest Information Update: 06 Nov 2021
Price :
$50
*
At a glance
- Originator American Biogenetic Sciences [CEASED]
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bipolar disorders; Epilepsy; Migraine
Most Recent Events
- 20 Sep 2002 Discontinued - Preclinical for Bipolar disorders in USA (unspecified route)
- 20 Sep 2002 Discontinued - Preclinical for Epilepsy in USA (unspecified route)
- 20 Sep 2002 Discontinued - Preclinical for Migraine in USA (unspecified route)